PAVM
PAVmed Inc.
+0.04 (+1.02%)3.96USD5.8K成交股數31.7M市值3.7本益比(近四季)282.7股價營收比+450.0%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 33K+450% | 22K+175% | 52K-95% | 5K-99% | 6K-99% | 8K-99% | 996K+26% | 979K+490% | 1.0M | 1.0M | 791K | 166K |
| 營業成本 | 122K | 97K | 86K | 55K | 41K | 36K | 1.4M | 1.7M | 1.7M | 1.6M | 1.8M | 1.7M |
| 毛利 | −89K+154% | −75K+168% | −34K-91% | −50K-93% | −35K-95% | −28K-95% | −385K-61% | −687K-55% | −734K | −561K | −988K | −1.5M |
| 毛利率 | -269.7% | -340.9% | -65.4% | -1,000.0% | -583.3% | -350.0% | -38.7% | -70.2% | -72.7% | -53.5% | -124.9% | -915.1% |
| 研發費用 | 2.1M | 1.4M | 1.8M | 1.1M | 790K | 787K | 1.5M | 1.6M | 1.9M | 3.6M | 3.2M | 3.5M |
| 銷售管理費用 | 4.7M | 6.4M | 4.7M | 3.5M | 3.7M | 4.4M | 6.6M | 7.0M | 6.7M | 7.0M | 6.9M | 6.7M |
| 營業利益 | −7.0M+49% | −8.0M+48% | −6.8M-41% | −4.8M-65% | −4.7M-66% | −5.4M-67% | −11.6M-25% | −13.7M-17% | −14.0M | −16.4M | −15.5M | −16.5M |
| 營業利益率 | -21,278.8% | -36,522.7% | -13,078.8% | -96,880.0% | -78,583.3% | -68,075.0% | -1,162.4% | -1,397.8% | -1,389.7% | -1,561.7% | -1,963.1% | -9,930.1% |
| 稅後淨利 | −5.4M-55% | −60K-100% | −5.4M-108% | −5.4M-50% | −11.9M-22% | 19.0M-218% | 64.4M-464% | −10.8M-26% | −15.2M | −16.1M | −17.7M | −14.5M |
| 淨利率 | -16,315.2% | -272.7% | -10,457.7% | -107,660.0% | -198,683.3% | 237,100.0% | 6,465.8% | -1,105.9% | -1,506.1% | -1,537.8% | -2,234.0% | -8,757.2% |
| 稀釋 EPS | -0.87-96% | -4.42-144% | 6.64+361% | -0.29-76% | -22.08+743% | 10.10-632% | 1.44-161% | -1.19-43% | -2.62 | -1.90 | -2.38 | -2.10 |
| 稀釋股數 | 6.3M | 1.6M | 670K | 21.6M | 603K | 1.7M | 44.5M | 9.2M | 8.7M | 7.2M | 7.5M | 7.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.8M | 6.5M | 1.5M | – | – | – | 765K | 25.5M | 25.5M | 19.6M | 26.4M | 37.2M |
| 應收帳款 | 16K | 21K | 15K | 3K | 3K | 9K | 16K | 219K | 67K | 61K | 36K | 41K |
| 存貨 | – | – | – | – | – | – | 6K | 687K | 410K | 278K | – | – |
| 總資產 | 40.2M | 45.4M | 38.8M | 38.1M | 43.9M | 52.8M | 30.6M | 39.4M | 37.3M | 33.1M | 42.0M | 53.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 20.9M | 20.4M | 16.5M | 12.3M | 12.5M | 11.9M | 39.9M | 58.1M | 57.8M | 57.1M | 57.8M | 54.5M |
| 股東權益 | 35.0M | 39.5M | 34.0M | 32.5M | 37.5M | 45.0M | −4.9M | −73.9M | −68.8M | −53.8M | −43.3M | −31.5M |
| 負債比 | 52.0% | 45.0% | 42.5% | 32.3% | 28.4% | 22.5% | 130.7% | 147.3% | 155.2% | 172.5% | 137.7% | 101.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.6M+66% | – | – | – | −1.6M | – | – | −13.1M | – | – | – |
| 資本支出 | – | 22K | – | – | – | 6K | – | – | 42K | – | – | – |
| 自由現金流 | – | −2.6M+66% | – | – | – | −1.6M | – | – | −13.2M | – | – | – |
| 折舊攤銷 | – | 20K | – | – | – | 43K | – | – | 586K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -12,009.1% | – | – | – | -19,837.5% | – | – | -1,302.1% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 71K | -97.6% | −3.8M | -5,315.5% | -5.63 | −5.2M |
| FY2024 | 3.0M | +22.1% | 32.0M | 1,067.3% | 14.90 | −33.6M |
| FY2023 | 2.5M | +550.4% | −66.3M | -2,702.7% | -9.16 | −52.3M |
| FY2022 | 377K | -24.6% | −89.0M | -23,602.9% | -15.03 | −72.5M |
| FY2021 | 500K | – | −50.3M | -10,069.4% | -0.65 | −42.1M |
| FY2020 | – | – | −34.3M | –% | -0.72 | −22.0M |
| FY2019 | – | – | −16.5M | –% | -0.54 | −13.4M |
| FY2018 | – | – | −18.0M | –% | -0.81 | −8.8M |